Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
NeuroOne Medical Technologies Corporation (NMTC) had Return on Equity of -38.81% for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$2.39M |
|
$-2.09M |
|
$1.10M |
|
$1.29M |
|
$4.49M |
|
$-2.10M |
|
$0.02M |
|
$-2.09M |
|
$-2.09M |
|
$-2.09M |
|
$-2.09M |
|
$-2.09M |
|
$-2.09M |
|
$-2.10M |
|
$-2.04M |
|
8.48M |
|
8.48M |
|
$-0.25 |
|
$-0.25 |
|
| Balance Sheet Financials | |
$7.40M |
|
$0.23M |
|
$0.46M |
|
$7.87M |
|
$1.69M |
|
-- |
|
$0.80M |
|
$2.49M |
|
$5.37M |
|
$5.34M |
|
$5.37M |
|
8.62M |
|
| Cash Flow Statement Financials | |
$-4.44M |
|
$-0.08M |
|
$0.76M |
|
$6.57M |
|
$2.80M |
|
$-3.77M |
|
$0.70M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.38 |
|
-- |
|
-- |
|
-- |
|
-- |
|
53.81% |
|
-87.86% |
|
-87.86% |
|
-- |
|
-87.22% |
|
-87.22% |
|
$-4.52M |
|
-- |
|
-- |
|
-- |
|
0.30 |
|
0.59 |
|
0.99 |
|
91.33 |
|
|
Return on Equity |
-38.81% |
-39.06% |
|
-26.52% |
|
-38.81% |
|
$0.62 |
|
$-0.53 |
|
$-0.52 |
|